The Scientist

» ebola, immunology and developmental biology

Most Recent

image: Ebola Vax Trial Update

Ebola Vax Trial Update

By | March 26, 2015

A novel Ebola vaccine being tested in China is safe and provokes a notable immune response in people, according to a Phase 1 trial.

0 Comments

image: Short, Strong Signals

Short, Strong Signals

By | March 25, 2015

Methylation increases both the activity and instability of the signaling protein Notch.

0 Comments

image: WHO: Ramp Up Vaccination

WHO: Ramp Up Vaccination

By | March 23, 2015

The World Health Organization is calling for an increase in routine vaccinations for measles and other preventable diseases in Ebola-affected countries.

0 Comments

image: T Cells of the Skin

T Cells of the Skin

By | March 18, 2015

A census of adaptive immune system components in human skin reveals a variety of resident and traveling memory T cells.

2 Comments

image: Elevated Measles Risk in Ebola-Stricken Regions

Elevated Measles Risk in Ebola-Stricken Regions

By | March 13, 2015

Decreased vaccination rates could lead to a deadlier measles outbreak, according to a study.

0 Comments

image: Fighting Allergy with Allergen

Fighting Allergy with Allergen

By | February 25, 2015

Babies who ate peanuts were less likely to develop an allergy to the food by the time they hit kindergarten, according to a new study.

4 Comments

image: Rapid Ebola Test Approved

Rapid Ebola Test Approved

By | February 24, 2015

The World Health Organization OKs the first 15-minute Ebola diagnostic test.

0 Comments

image: Ebola Victims Still Infectious a Week After Death

Ebola Victims Still Infectious a Week After Death

By | February 12, 2015

Ebola virus can remain infectious for up to seven days on the bodies of monkeys that died from the disease, researchers show.

0 Comments

image: Long-Lived Immunotherapy Stem Cells

Long-Lived Immunotherapy Stem Cells

By | February 4, 2015

Genetically modified T memory stem cells persist in patients for more than 10 years, and can differentiate into a variety of T cell types.

1 Comment

image: Ebola Drug Trial Canceled

Ebola Drug Trial Canceled

By | February 2, 2015

As the number of Ebola cases declines, Chimerix is unable to recruit enough patients for its trial in Liberia testing the antiviral drug brincidofovir.

0 Comments

Popular Now

  1. Top 10 Innovations 2016
    Features Top 10 Innovations 2016

    This year’s list of winners celebrates both large leaps and small (but important) steps in life science technology.

  2. Gut Microbes Linked to Neurodegenerative Disease
  3. Pubic Hair Grooming Linked to STI Risk
    The Nutshell Pubic Hair Grooming Linked to STI Risk

    Observational study suggests pubic hair grooming correlates with heightened risk of acquiring sexually transmitted infections, although causation remains unclear.

  4. Naive T Cells Find Homes in Lymphoid Tissue
Rockland